Conversely, these findings indicate that activation of GPR55 by increased lysophosphatidylinositols in hepatocytes and adipocytes results in the accumulation of fats and is associated with human obesity and metabolic disorders, suggesting the therapeutic potential of GPR55 in obesity-related diseases. This evidence concerns the gene GPR55 and obesity due to melanocortin 4 receptor deficiency.